Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Regeneron: Sanofi Plans to Increase Stake to Over $500 Million of Stock

02/11/2013 | 10:44am US/Eastern
   By Melodie Warner 
 

Regeneron Pharmaceuticals Inc. (>> Regeneron Pharmaceuticals Inc) said Sanofi S.A. (SNY, SAN.FR) notified the biopharmaceutical company of its intent to boost its investment in the company and push its ownership of voting securities to more than $500 million.

Sanofi currently holds about 17% of Regeneron's shares outstanding, according to FactSet Research.

Regeneron said a December 2007 investor agreement bonds the French drug maker to certain standstill provisions, including an agreement not to acquire more than 30% of Regeneron's Class A stock and common stock outstanding.

Regeneron said these standstill provisions are in effect until the fifth anniversary of the expiration of a license and collaboration agreement between the companies.

Sanofi and Regeneron have worked together on experimental cancer drug Zaltrap, among other things.

Shares of Regeneron rose 5.6% to $175.13 in recent trading and have climbed 24% in the past three months.

Write to Melodie Warner at melodie.warner@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Regeneron Pharmaceuticals Inc
React to this article
Latest news on REGENERON PHARMACEUTICALS
04:51p Amgen profit tops Street view, boosts full-year forecast
07:31a REGENERON PHARMACEUTICALS : Assigned Patent
07/29 REGENERON PHARMACEUTICALS : and Sanofi Announce CHMP Recommends European Approva..
07/29 REGENERON PHARMACEUTICALS : Pharma Enters into Co-Development Agreement with San..
07/28DJSANOFI : Regeneron Enter Major New Immuno-Oncology Collaboration
07/24DJFDA Approves Cholesterol Drug From Regeneron, Sanofi -- UPDATE
07/24DJFDA Approves Cholesterol Drug From Regeneron, Sanofi
07/24DJFDA Approves Cholesterol Drug From Regeneron, Sanofi
07/22 REGENERON PHARMACEUTICALS : Patent Issued for Humanized IL-6 and IL-6 Receptor
07/21 REGENERON PHARMACEUTICALS : NASDAQ:REGN) Shareholder Notice: Investigation over ..
Advertisement
Chart
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Income Statement Evolution
More Financials